Role of tachykinins in hyperpnea-induced bronchovascular hyperpermeability in guinea pigs. 1991

A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
Department of Medicine, University of Chicago, Illinois 60637.

Isocapnic dry gas hyperpnea causes bronchoconstriction in guinea pigs that is mediated by release of tachykinins from airway sensory nerves. Exogenous neuropeptides can induce microvascular leak. Therefore we tested whether dry gas hyperpnea also elicits bronchovascular hyperpermeability by measuring Evans blue-labeled albumin extravasation along the airways of mechanically ventilated guinea pigs. We found that 1) room temperature dry gas hyperpnea increased Evans blue extravasation in extrapulmonary and intrapulmonary airways as a specific consequence of local airway heat/water losses, 2) capsaicin pretreatment ablated the bronchoconstrictor response to dry gas hyperpnea and reduced bronchovascular leak only in intrapulmonary airways, 3) phosphoramidon given to capsaicin-pretreated animals partially restored dry gas hyperpnea-induced bronchoconstriction and increased the vascular hyperpermeability response to hyperpnea in intrapulmonary airways, and 4) propranolol administration had no important effects on any of these airway responses. We conclude that dry gas hyperpnea causes bronchovascular hyperpermeability in guinea pigs. Tachykinins have a dominant role in this response in the intrapulmonary airways, although another mechanism may also contribute to the microvascular leak in the extrapulmonary airways.

UI MeSH Term Description Entries
D006985 Hyperventilation A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide. Hyperventilations
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015320 Tachykinins A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors. Tachykinin

Related Publications

A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
March 1989, Journal of applied physiology (Bethesda, Md. : 1985),
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
July 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
November 1999, Naunyn-Schmiedeberg's archives of pharmacology,
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
June 1996, Journal of applied physiology (Bethesda, Md. : 1985),
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
September 1993, Journal of applied physiology (Bethesda, Md. : 1985),
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
December 1989, Journal of applied physiology (Bethesda, Md. : 1985),
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
July 1996, Environmental toxicology and pharmacology,
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
October 1994, British journal of pharmacology,
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
July 1990, Respiration physiology,
A Garland, and D W Ray, and C M Doerschuk, and L Alger, and S Eappon, and C Hernandez, and M Jackson, and J Solway
March 2002, European journal of pharmacology,
Copied contents to your clipboard!